An open-label phase 2 trial to assess the efficacy, safety and pharmacokinetics of lanthanum carbonate in hyperphosphatemic children and adolescents with chronic kidney disease undergoing dialysis

BACKGROUND: This study assessed the efficacy, tolerability and pharmacokinetics (PK) of lanthanum carbonate (LC) in hyperphosphatemic children and adolescents with chronic kidney disease (CKD) undergoing dialysis. METHODS: This was a three-part, multicenter, open-label study of LC (oral powder formu...

Descripción completa

Detalles Bibliográficos
Autores principales: Wasilewska, Anna, Murray, Rose Ann, Sundberg, Aimee, Uddin, Sharif, Achenbach, Heinrich, Shavkin, Aleksey, Szabó, Tamás, Vergani, Andrea, Umeh, Obi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892701/
https://www.ncbi.nlm.nih.gov/pubmed/35236302
http://dx.doi.org/10.1186/s12882-022-02688-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892701/
https://www.ncbi.nlm.nih.gov/pubmed/35236302
http://dx.doi.org/10.1186/s12882-022-02688-9

Ejemplares similares